Your browser doesn't support javascript.
loading
Chronic gvhd dictionary-eurograft cost action initiative consensus report.
Zelic Kerep, Ana; Olivieri, Atillio; Schoemans, Helene; Lawitschka, Anita; Halter, Jörg; Pulanic, Drazen; Dickinson, Anne; Greinix, Hildegard T; Pavletic, Steven Z; Schultz, Kirk R; Lee, Stephanie J; Wolff, Daniel.
Afiliação
  • Zelic Kerep A; Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia. azelic987@gmail.com.
  • Olivieri A; Department of Clinical and Molecular Sciences, University of Ancona, Ancona, Italy.
  • Schoemans H; Department of Hematology, University Hospital Leuven, Leuven, Belgium.
  • Lawitschka A; Deparment of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, Leuven, Belgium.
  • Halter J; Stem Cell Transplant Unit, St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
  • Pulanic D; Division of Hematology, University Hospital Basel, Basel, Switzerland.
  • Dickinson A; Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
  • Greinix HT; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Pavletic SZ; Hematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
  • Schultz KR; Division of Hematology, Medical University Graz, Graz, Austria.
  • Lee SJ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wolff D; Division of Hematology/Oncology/BMT, British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
Bone Marrow Transplant ; 58(1): 68-71, 2023 01.
Article em En | MEDLINE | ID: mdl-36229646
Chronic graft versus host disease (cGVHD) affects patients after allogeneic hematopoietic stem cell transplantation (alloHSCT). This orphan disease poses a challenge for clinicians and researchers. The purpose of the cGVHD Dictionary is to provide a standardized structure for cGVHD databases on an international level, reconciling differences in data retrieval and facilitate database merging. It is derived from several consensus meetings of the EUROGRAFT consortium (European Cooperation in Science and Technology-COST Action CA17138) followed by a consensus process involving European Society for Blood and Marrow Transplantation (EBMT), US GvHD consortium and Center for International Bone Marrow Transplant Registry (CIBMTR). Databases used for the dictionary were: the National Institutes of Health (NIH) database, the Center for International Blood and Marrow Transplant Research, Applying Biomarkers to Minimize Long Term Effects of Childhood/Adolescent Cancer Treatment - Pediatric Blood and Marrow Transplant Consortium database, EBMT registry, the German-Austrian-Swiss GvHD registry, Italian Blood and Marrow Transplantation Society registry and Regensburg-Göttingen-Newcastle HSCT dataset. A four-part cGVHD Dictionary was formed based on the databases, consensus, and evidence in the literature. The Dictionary is divided into: (1) Patient characteristics, (2) Transplant characteristics, (3) cGVHD characteristics and (4) patient-reported quality of life, symptom burden and functional indicators.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Síndrome de Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Tipo de estudo: Health_economic_evaluation Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Síndrome de Bronquiolite Obliterante / Doença Enxerto-Hospedeiro Tipo de estudo: Health_economic_evaluation Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article